Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC). (Q48657743)
Jump to navigation
Jump to search
scientific article published on 20 February 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC). |
scientific article published on 20 February 2012 |
Statements
1 reference
Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC). (English)
1 reference
Nicole R Gonzales
1 reference
Jharna Shah
1 reference
Navdeep Sangha
1 reference
Lenis Sosa
1 reference
Rebecca Martinez
1 reference
Loren Shen
1 reference
Mallikarjunarao Kasam
1 reference
Miriam M Morales
1 reference
M Monir Hossain
1 reference
Andrew D Barreto
1 reference
Sean I Savitz
1 reference
George Lopez
1 reference
Vivek Misra
1 reference
Tzu-Ching Wu
1 reference
Ramy El Khoury
1 reference
Amrou Sarraj
1 reference
Preeti Sahota
1 reference
William Hicks
1 reference
Indrani Acosta
1 reference
M Rick Sline
1 reference
Mohammad H Rahbar
1 reference
Xiurong Zhao
1 reference
Jaroslaw Aronowski
1 reference
James C Grotta
1 reference
20 February 2012
1 reference
8
1 reference
5
1 reference
388-396
1 reference